SCHEMBL13460145

SCHEMBL13460145

Cc1cc(N2CCNCC2)ccc1NO

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB1 P08588 10/20 0.65
▸ HTR7 P34969 4/20 0.47
▸ HTR3E A5X5Y0 5/20 0.46
▸ HTR3B O95264 5/20 0.46
▸ HTR3A P46098 5/20 0.46
▸ HTR3D Q70Z44 5/20 0.46
▸ HTR3C Q8WXA8 5/20 0.46
▸ SIGMAR1 Q99720 5/20 0.46
▸ HTR5A P47898 1/20 0.46
▸ MAPT P10636 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ HTR1A P08908 4/20 0.46
▸ HTR1D P28221 1/20 0.43
▸ HTR1B P28222 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ HTR6 P50406 3/20 0.42
▸ TP53 P04637 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL221254 0.79 ADRB1 (1.00) ADRB1HTR7HTR3EHTR3BHTR3A
SCHEMBL24670708 0.79 MEN1 (0.55) ADRB1MAPTALDH1A1TP53HTR2A
SCHEMBL29803340 0.79 ADRB1 (0.54) ADRB1MAPTALDH1A1HTR6
SCHEMBL14747891 0.78 ADRB1 (0.71) ADRB1HTR7HTR3EHTR3BHTR3A
SCHEMBL13460198 0.77 USP2 (0.47) ADRB1HTR7HTR3EHTR3BHTR3A
Bromide SCHEMBL9382071 0.77 ADRB1 (0.69) ADRB1HTR7HTR3EHTR3BHTR3A
SCHEMBL1600023 0.75 ADRB1 (0.71) ADRB1HTR7HTR3EHTR3BHTR3A
SCHEMBL20171856 0.75 ADRB1 (0.71) ADRB1HTR7HTR3EHTR3BHTR3A
SCHEMBL2874530 0.75 ADRB1 (0.71) ADRB1HTR7HTR3EHTR3BHTR3A
SCHEMBL1022323 0.75 ADRB1 (0.71) ADRB1HTR7HTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010031707-A1 NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2010-03-25 — — WO disclosed
Send feedback